15 Companies Developing Hair Loss Treatments And Their Current Statuses
- Thread starter Toccata
- Start date
- Reaction score
- 850
It’s well known that Follicle Thought is a crappy blog with questionable info.
Well thank you for not posting from there, Fuji.
- Reaction score
- 820
Hello! I am Fuji Maru Kagurazaka.
I live in Tokyo, Japan. Thank you.
If "Follicle Thought" is in doubt, my blog will be similar as well.
I live in Japan and can not speak English.
News in English-speaking countries writes articles using translation functions, but it is quite uncertain.
It is a blogger's pleasure to send information to people who suffer from alopecia and give dreams and peace of mind ....
May God bless your scalp！
I live in Tokyo, Japan. Thank you.
If "Follicle Thought" is in doubt, my blog will be similar as well.
I live in Japan and can not speak English.
News in English-speaking countries writes articles using translation functions, but it is quite uncertain.
It is a blogger's pleasure to send information to people who suffer from alopecia and give dreams and peace of mind ....
May God bless your scalp！
- Reaction score
- 850
Your blog’s contents? Doubtful?
- Reaction score
- 820
Hello! I am Fuji Maru Kagurazaka.
I live in Tokyo, Japan. Thank you.
Suspicion is that I do not use it or verify it myself.
I am looking for topics mainly in English-speaking countries every day.
And write with your own sentences.
It can not be verified at all.
My blog has the following site policy.
We only keep in mind that such research and development and products exist in Japan and abroad.
【Site Policy on Pharmaceuticals】
In "Hair Loss Cure JAPAN" which operates and manages the Fuji Maru Kagurazaka, it is strongly recommended that medical drugs be consulted at a medical institution and diagnosed by a doctor, and regular products will be used under prescription.
Also, we strongly recommend that you purchase general-purpose medicines with face-to-face sales at pharmacies and drug stores where pharmacists are resident.
We strongly deny the act of purchasing copy products that assert the same principal component produced in Japan and unknown medicines and developing countries in on-line mail order and using it except under the control of the doctor even though it is self-responsibility.
We do not use profit-inducing programs such as affiliate program and Google adsense to promote fraudulent acts on this site.
May God bless your scalp！
- Reaction score
- 820
Hello! I am Fuji Maru Kagurazaka.
I live in Tokyo, Japan. Thank you.
Although it can not be verified, there is no intentional transmission of fake news
May God bless your scalp！
I live in Tokyo, Japan. Thank you.
Although it can not be verified, there is no intentional transmission of fake news
May God bless your scalp！
- Reaction score
- 1,326
Can someone update me on this: I believe there were two other companies beside Tsuji that were working on follicle neogenisis in native scalp or in culture. I'm not one who will now get anything from maintenance, so can you update me on this?
Hairlclone and TissUse, both european I think. Don't know much about Hairlclone, but I emailed TissUse a few weeks ago and they said they were planning the first clinical trials to prove safety first.
And that "this also means that it will still take a couple of more years before SHT will be broadly available as an alternative to conventional hair transplantation methods"
Noisette
Established Member
- Reaction score
- 1,341
TissUse from Germany, the respected Professor Lauster Roland. Their technology is called " SHT = Smart Hair Transplants"
" Hair transplantation is a procedure that is currently invasive and costly. The current industry standard requires the surgical excision of a skin flap that contains roughly 8,000 hairs, and yields roughly 8,000 hairs upon transplantation. TissUse has discovered a more efficient and less painful process. By isolating cells from the dermal papilla, the root of the hair follicle, it is possible to expand and culture those cells to form neopapillae
Neopapillae are the precursors of hair follicles which have been shown to grow hair follicles under controlled conditions in vitro. The approach is extremely efficient compared to the standard and requires the cells from thirty punch biopsies only, while yielding 10,000 neopapillae (three hundred fold more transplants).
Each of these neopapilla has the potential to form a brand new hair follicle. TissUse’s method of hair restoration requires exceptional few biopsies and yields large numbers of hair inducing transplants while being much less invasive than the surgical transplant standard! Proof of Concept in clinical trials is the next value adding milestone toward clinical application and commercial use ".
source: https://www.tissuse.com/en/products/regenerative-therapies/
" Hair transplantation is a procedure that is currently invasive and costly. The current industry standard requires the surgical excision of a skin flap that contains roughly 8,000 hairs, and yields roughly 8,000 hairs upon transplantation. TissUse has discovered a more efficient and less painful process. By isolating cells from the dermal papilla, the root of the hair follicle, it is possible to expand and culture those cells to form neopapillae
Neopapillae are the precursors of hair follicles which have been shown to grow hair follicles under controlled conditions in vitro. The approach is extremely efficient compared to the standard and requires the cells from thirty punch biopsies only, while yielding 10,000 neopapillae (three hundred fold more transplants).
Each of these neopapilla has the potential to form a brand new hair follicle. TissUse’s method of hair restoration requires exceptional few biopsies and yields large numbers of hair inducing transplants while being much less invasive than the surgical transplant standard! Proof of Concept in clinical trials is the next value adding milestone toward clinical application and commercial use ".
source: https://www.tissuse.com/en/products/regenerative-therapies/
- Reaction score
- 850
Do you know when the clinical trials are going to begin? Have they got clearance/approval?
Thanks Noisette. Very useful and interesting information, as always.
These therapies will be the next era in the hair trasplants, for sure.
Interesting news today. The first (or one of the first patients) treated with PolarityTE has given his thoughts on the treatment. He comments that the regenerated skin has even got hair follicles!
This is a product, out on the market now, that can regenerate hair in wounds. To me, thats quite exciting and I hope they can commercialise a use in Androgenetic Alopecia like theyve stated they want to. They just recently raised 30 million dollars as well.
https://ir.polarityte.com/press-releases/detail/423
This is a product, out on the market now, that can regenerate hair in wounds. To me, thats quite exciting and I hope they can commercialise a use in Androgenetic Alopecia like theyve stated they want to. They just recently raised 30 million dollars as well.
https://ir.polarityte.com/press-releases/detail/423
Noisette
Established Member
- Reaction score
- 1,341
Thanks bro
Have you read the excellent interview of TissUse made by @Swoop for HairLossTalk.com ? In case of, you have no seen it here : https://www.hairlosstalk.com/news/new-research/tissuse-smart-hair-transplants/
"
HairLossTalk.com: When will the method be tested out in humans as a proof of concept study? If everything goes well, when would be the quickest release on the market so that everyone can access it?
This depends on available funding for a proof of concept. We estimate it will take at least 3 years to finalize the first clinical trials. "
As soon as I have a little time I will try to find more informations about them
+1 nice ! Thank you !
- Reaction score
- 850
At least three years for finalising first clinical trials? And that is if they get funding.Thanks bro
https://www.hairlosstalk.com/news/new-research/tissuse-smart-hair-transplants/
"
HairLossTalk.com: When will the method be tested out in humans as a proof of concept study? If everything goes well, when would be the quickest release on the market so that everyone can access it?
This depends on available funding for a proof of concept. We estimate it will take at least 3 years to finalize the first clinical trials. "
As soon as I have a little time I will try to find more informations about them
+1 nice ! Thank you !
I guess it’s safe to set a 10 year timeline for this one.
Still, let’s hope this works.
Tauji’s treatment will undergo human trials in 2019. That’s what’s planned anyway. How much time should we realistically expect, if the trials are successful?
Aclaris exited the hair loss market, Brotzu was DoA, and the rest probably completely missed the expected deadlines of people in this forum generally, or are decades behind.
The closest one is Samumed which is in phase 3. However Winlevi phase 3 was completed in 2018 - still not released, Breezula phase 3 hasn't even started. Follica 'announced' phase 3. The others are far behind.
While new treatments are closer than ever, and the number of them is higher than ever, being optimistic only leads to disappointment.
The closest one is Samumed which is in phase 3. However Winlevi phase 3 was completed in 2018 - still not released, Breezula phase 3 hasn't even started. Follica 'announced' phase 3. The others are far behind.
While new treatments are closer than ever, and the number of them is higher than ever, being optimistic only leads to disappointment.
Winlevi got FDA approval.
Yea and 10% of adolescents will have issues with their HPA axis and 5% of adults. And this is with the 1% version!! WTH
Atleast they are probably honest, unlike finastride 1%.
It's not as bad as it sounds. Adolescents will more easily have problems from drugs that alter or block hormones. The 5% rate in adults is only 1% more than with vehicle, so it's actually quite low.
You are right. But think about 7% these percentage could be 7 folds.
Let's hope it do not have permanent sides like finasteride.
That would be enough atleast people can try without fear.